Skip to main content
Home > Week in Review > Management

Chronological Index of : Management Tracks

 Current Issue
  • Adaptimmune board of directors update

    Adaptimmune Ltd., Abingdon, U.K. Business: Cancer, Infectious, Gene/Cell therapy Appointed: Ali Behbahani, partner at New Enterprise Associates; David Mott, general partner at NEA; and Peter Thompson, private equity …

    Published on 9/29/2014
  • AmpliPhi BioSciences management update

    AmpliPhi Biosciences Corp. (OTCBB:APHB), Richmond, Va. Business: Infectious, Autoimmune, Gene/Cell therapy Resigned: Phillip Young as president and CEO, while remaining a director; Jeremy Cook, chairman, becomes interim…

    Published on 9/29/2014
  • Avalanche Biotechnologies management update

    Avalanche Biotechnologies Inc. (NASDAQ:AAVL), Menlo Park, Calif. Business: Ophthalmic Hired: Roman Rubio as SVP and head of translational medicine, formerly global head of ophthalmology at Roche's Genentech Inc. unit

    Published on 9/29/2014
  • Biogen Idec management update

    Biogen Idec Inc. (NASDAQ:BIIB), Weston, Mass. Business: Biopharmaceuticals Hired: Olivier Danos as SVP of gene therapy, formerly SVP of molecular medicine, synthetic biology and gene regulation at Kadmon Corp. LLC

    Published on 9/29/2014
  • Celgene management update

    Celgene Corp. (NASDAQ:CELG), Summit, N.J. Business: Biopharmaceuticals Transitioned: Tuomo Patsi to president of the Europe, Middle East and Africa region at Celgene's Celgene International S.a.r.l. subsidiary from …

    Published on 9/29/2014
  • Cevec management update

    Cevec Pharmaceuticals GmbH, Cologne, Germany Business: Supply/Service, Biomanufacturing Hired: Frank Ubags as COO, formerly COO of Scil Proteins GmbH Transitioned: Nicole Faust to CSO from VP of development and …

    Published on 9/29/2014
  • ChemoCentryx management update

    ChemoCentryx Inc. (NASDAQ:CCXI), Mountain View, Calif. Business: Autoimmune, Inflammation, Cancer Hired: Israel Charo as SVP of research

    Published on 9/29/2014
  • GlaxoSmithKline board of directors update

    GlaxoSmithKline plc (LSE:GSK; NYSE:GSK), London, U.K. Business: Pharmaceuticals Appointed: Philip Hampton as non-executive director, effective January 1, 2015; he will become a deputy chairman effective April 1, 2015 …

    Published on 9/29/2014
  • Highland Therapeutics management update

    Highland Therapeutics Inc., Toronto, Ontario Business: Drug delivery Hired: Floyd Sallee as CMO of Highland's Ironshore Pharmaceuticals & Development Inc. subsidiary

    Published on 9/29/2014
  • International Partnership for Microbicides management update

    International Partnership for Microbicides, Silver Spring, Md. Business: Infectious Hired: Lynn Bodarky as EVP of global product access, a newly created position, formerly senior director of public sector investment and…

    Published on 9/29/2014
  • Kadmon management update

    Kadmon Corp. LLC, New York, N.Y. Business: Cancer, Infectious Hired: Harlan Waksal, a director, as president and CEO; he succeeds his brother Samuel Waksal as CEO; Samuel remains chairman and becomes chief of …

    Published on 9/29/2014
  • Medidata Solutions management update

    Medidata Solutions Inc. (NASDAQ:MDSO), New York, N.Y. Business: Bioinformatics Hired: Michael Capone as COO, a newly created position, formerly corporate VP of product development and chief information officer of ADP …

    Published on 9/29/2014
  • Merus Labs International management update

    Merus Labs International Inc. (TSX:MSL; NASDAQ:MSLI), Toronto, Ontario Business: Infectious, Dermatology Resigned: Elie Farah as CEO and a director; Senior Advisor Barry Fishman becomes interim CEO and a director

    Published on 9/29/2014
  • Ophthotech management update

    Ophthotech Corp. (NASDAQ:OPHT), New York, N.Y. Business: Ophthlamic Hired: Michael Atieh as EVP, CFO, CBO and treasurer; he succeeds Bruce Peacock, who is retiring

    Published on 9/29/2014
  • SiteOne board of directors update

    SiteOne Therapeutics Inc., San Francisco, Calif. Business: Neurology Appointed: Lowell Sears, chief investment officer, CEO and chairman of Sears Capital Management Inc.; and Joe Zakrzewski, formerly CEO and chairman of…

    Published on 9/29/2014
  • Synageva management update

    Synageva BioPharma Corp. (NASDAQ:GEVA), Lexington, Mass. Business: Endocrine/Metabolic, Infectious Hired: Robert Bazemore as COO, formerly president of Johnson & Johnson's Janssen Biotech Inc. subsidiary

    Published on 9/29/2014
  • Tracon board of directors update

    Tracon Pharmaceuticals Inc., San Diego, Calif. Business: Cancer Appointed: Paul Walker, partner at New Enterprise Associates

    Published on 9/29/2014
  • Tracon management update

    Tracon Pharmaceuticals Inc., San Diego, Calif. Business: Cancer Hired: Patricia Bitar as CFO, formerly VP and corporate controller at NuVasive Inc.

    Published on 9/29/2014
  • Transgene management update

    Transgene S.A. (Euronext:TNG), Illkirch, France Business: Cancer, Infectious Hired: Eric Quemeneur as EVP of R&D, formerly director of research programs and industrial partnerships in the life sciences division at the …

    Published on 9/29/2014
  • Adenium Biotech management update

    Adenium Biotech ApS, Copenhagen, Denmark Business: Infectious Hired: Edward Fang as CMO, formerly director of clinical sciences at Trius Therapeutics Inc., which Cubist Pharmaceuticals Inc. acquired

    Published on 9/22/2014
  • Alexion management update

    Alexion Pharmaceuticals Inc. (NASDAQ:ALXN), Cheshire, Conn. Business: Hematology, Neurology, Endocrine/Metabolic Hired: Edward Miller as SVP and chief compliance officer, a newly created position Promoted: Clare …

    Published on 9/22/2014
  • Alnylam management update

    Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY), Cambridge, Mass. Business: Infectious, Endocrine/Metabolic, Cancer Hired: Karen Anderson as SVP and chief human resources officer, formerly VP of human resources for R&D and …

    Published on 9/22/2014
  • Antares management update

    Antares Pharma Inc. (NASDAQ:ATRS), Ewing, N.J. Business: Drug delivery Promoted: Robert Apple to COO, a newly created position, from EVP and president of the parenteral products group, while remaining CFO until a …

    Published on 9/22/2014
  • Array BioPharma management update

    Array BioPharma Inc. (NASDAQ:ARRY), Boulder, Colo. Business: Cancer, Inflammation, Chemistry Hired: Victor Sandor as CMO, formerly SVP of global clinical development at Incyte Corp.; he succeeds Michael Needle

    Published on 9/22/2014
  • Dimension Therapeutics management update

    Dimension Therapeutics, Cambridge, Mass. Business: Gene/Cell therapy, Hematology Hired: Annalisa Jenkins as CEO and a director, formerly EVP and head of global R&D at the Merck Serono S.A. biopharmaceutical division of …

    Published on 9/22/2014

< Previous   1  2  3  4  5  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993